Scholarlink

<p>Cognitive deficits are a core feature of schizophrenia, emerging early and strongly influencing functional outcomes. However, the role of the nitric oxide (NO) signaling pathway in drug-naïve, first-episode schizophrenia remains unclear. To investigate the relationship between the nitric oxide synthase (NOS) system and cognitive function, we studied 98 first-episode, drug-naïve schizophrenia patients and 96 matched healthy controls. Plasma levels of inducible NOS (iNOS), total NOS (TNOS), the iNOS/TNOS ratio, malondialdehyde (MDA), and hydrogen peroxide (H₂O₂) were measured. Psychopathological symptoms and cognitive performance were assessed using the Positive and Negative Syndrome Scale (PANSS) and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), respectively. Group differences and associations among NOS markers, cognitive domains, and symptom severity were examined. Patients exhibited marked NOS system dysfunction, characterized by reduced iNOS and TNOS levels, a lower iNOS/TNOS ratio, elevated MDA levels, and reduced H₂O₂ concentrations. TNOS levels were positively associated with RBANS total score and multiple cognitive domains, independent of PANSS total score, whereas iNOS levels were associated only with immediate memory. The iNOS/TNOS ratio showed no independent association with cognition. In addition, TNOS levels were correlated with PANSS total score, suggesting that overall NOS function reflects disease burden. These findings indicate that early schizophrenia is characterized by NOS system dysfunction. Overall NOS activity, rather than relative NOS subtype expression, is closely linked to multidimensional cognitive impairment and is partly independent of symptom severity.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Abnormalities in nitric oxide synthase system function and their association with cognitive function in first-episode schizophrenia patients

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月12日

查看全文
  • Fei Jiang,
  • Jie Hou,
  • Qun Yang,
  • Peijuan Wang,
  • Lei Ji,
  • Jing Cao,
  • Xiaoying Zhang,
  • Qing Tian,
  • Xiaobin Zhang

摘要

Cognitive deficits are a core feature of schizophrenia, emerging early and strongly influencing functional outcomes. However, the role of the nitric oxide (NO) signaling pathway in drug-naïve, first-episode schizophrenia remains unclear. To investigate the relationship between the nitric oxide synthase (NOS) system and cognitive function, we studied 98 first-episode, drug-naïve schizophrenia patients and 96 matched healthy controls. Plasma levels of inducible NOS (iNOS), total NOS (TNOS), the iNOS/TNOS ratio, malondialdehyde (MDA), and hydrogen peroxide (H₂O₂) were measured. Psychopathological symptoms and cognitive performance were assessed using the Positive and Negative Syndrome Scale (PANSS) and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), respectively. Group differences and associations among NOS markers, cognitive domains, and symptom severity were examined. Patients exhibited marked NOS system dysfunction, characterized by reduced iNOS and TNOS levels, a lower iNOS/TNOS ratio, elevated MDA levels, and reduced H₂O₂ concentrations. TNOS levels were positively associated with RBANS total score and multiple cognitive domains, independent of PANSS total score, whereas iNOS levels were associated only with immediate memory. The iNOS/TNOS ratio showed no independent association with cognition. In addition, TNOS levels were correlated with PANSS total score, suggesting that overall NOS function reflects disease burden. These findings indicate that early schizophrenia is characterized by NOS system dysfunction. Overall NOS activity, rather than relative NOS subtype expression, is closely linked to multidimensional cognitive impairment and is partly independent of symptom severity.